Return to content in this issue


Safety and Effectiveness of Dupilumab in Prurigo Nodularis

Romano C

Clinical Immunology Outpatient Clinic – Division of Internal Medicine, Department of Advanced Medical and Surgical Sciences, “Luigi Vanvitelli” University of Campania, Naples, Italy

J Investig Allergol Clin Immunol 2021; Vol 31(2) : 162-163
doi: 10.18176/jiaci.0550

Key words: Dupilumab, Prurigo nodularis, Safety, Congestive heart failure

Title Type Size
doi10.1876_jiaci.0550_material-suppl_1.pdf pdf 577.63 Kb